Potential role of geranylgeraniol in managing statin-associated muscle symptoms: a COVID-19 related perspective
Description
Myopathy is the most common side effect of statins, but it has not been addressed effectively. In anticipation of its wider use as a small molecule to complement the current COVID-19 management, a pharmacological solution to statin-associated muscle